NCT01118689 2013-08-02Dose Escalation Study of MLN0128 in Relapsed or Refractory Multiple Myeloma or Waldenstrom MacroglobulinemiaMillennium Pharmaceuticals, Inc.Phase 1 Completed39 enrolled